Page 5 - Critical Study News Today

DEFINITELY not, especially in terms of the most important field that determines whether we are independent or not: our foreign relations.

DEFINITELY not, especially in terms of the most important field that determines whether we are independent or not: our foreign relations. Except for the six-year (or even five) hiatus after President Rodrigo Duterte declared his policy of "separating" from the US, and when President Gloria Arroyo in 2004 refused to participate anymore in the American illegal invasion of Iraq, we have always been the American toady in our relations with the...

By Prof. Dr. Mary Josephine Jerina Dr. P.V. Laxmiprasad, a renowned author, literary critic, a resource person and a senior editor has so far published 42 books in English literature. Besides, he has to his credit 70 research papers, 120 poems, 55 book reviews, a few translations and held interviews with literary legends. All his

Nehru and Ambedkar did not differ much in terms of ideology, but had significantly contrasting views about their execution, particularly with regard to their ideas on caste reservations, codification of Hindu law, and foreign policy. Kashmir too was an issue on which these two founders of modern India differed drastically.

New London ― As Connecticut College models walked two at a time to the vibes of Beyonce, Azealia Banks and Cookiee Kawaii in one of their rehearsals, runway manager Xenia Bernal flitted between the co...

Books reconstructing the life of Jesus are numerous. They are typically idealistic and focus on Jesus as a great man who changed the course of history through his decisions and deeds.

New London ― The ALL IN Campus Democracy Challenge, an initiative from the nonprofit Civic Nation to increase civic engagement on college campuses, has recognized Connecticut College as part of its i...

California State Sen. Nancy Skinner announced $3 million in funding for the UC Berkeley Latinx Research Center on Friday.  

~ Critical Study to Support Abuse Deterrent Labeling ~SAN DIEGO, CA / ACCESSWIRE / October 28, 2022 / Ensysce Biosciences, Inc. ("Ensysce" or the "Company") (NASDAQ:ENSC)(OTC PINK:ENSCW), a clinical-stage

(RNS) — Meier spent years arguing that faith and scientific research could enliven biblical scholarship about the life of Jesus.